Calcineurin involvement in the regulation of high-threshold Ca2+ channels in NG108-15 (rodent neuroblastoma x glioma hybrid) cells

被引:28
|
作者
Lukyanetz, EA
Piper, TP
Sihra, TS
机构
[1] Royal Free Hosp, Sch Med, Dept Pharmacol, London NW3 2PF, England
[2] AA Bogomolets Physiol Inst, UA-252601 Kiev 24, Ukraine
来源
JOURNAL OF PHYSIOLOGY-LONDON | 1998年 / 510卷 / 02期
基金
英国惠康基金;
关键词
D O I
10.1111/j.1469-7793.1998.371bk.x
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
1. We examined the relationship between calcineurin (protein phosphatase 2B (PP2B)) and voltage-operated Ca2+ channels (VOCCs) in NG108-15 cells. PP2B expression in NG108-15 cells was altered by transfection with plasmid constructs containing a full length cDNA of human PP2B beta(3) in sense (CN-15) and antisense (CN-21) orientation. 2. Confocal immunocytochemical localization showed that in wild-type cells, PP2B immunoreactivity is uniformly distributed in undifferentiated cells and located at the inner surface of soma membrane and neurites in differentiated cells. 3. To test the Ca2+ dependence of the VOCC, we used high-frequency stimulation (HFS). The L- and N-type VOCCs decreased by 37 and 52%, respectively, whereas the T-type current was only marginally sensitive to this procedure. FK-506 (2 mu M), a specific blocker of PP2B, reduced the inhibition of L- and N-type VOCCs induced by HFS by 30 and 33%, respectively. 4. In CN-15-transfected cells overxpressing PP2B, total high-voltage-activated (HVA) VOCCs were suppressed by about 60% at a test potential of +20 mV. Intracellular addition of EGTA or FK-506 into CN-15-transfected cells induced an up to 5-fold increase of HVA VOCCs. 5. These findings indicate that PP2B activity does not influence the expression of HVA C2+ channels, but modulates their function by C2+-dependent dephosphorylation. Thus HVA VOCCs, in a phosphorylated state under control conditions, are downregulated by PP2B upon stimulation, with the major effect being on N-type VOCCs.
引用
收藏
页码:371 / 385
页数:15
相关论文
共 50 条
  • [1] EVIDENCE FOR A NA+/CA2+ EXCHANGER IN NEUROBLASTOMA X GLIOMA HYBRID NG108-15 CELLS
    HSU, LS
    CHOU, WY
    CHUEH, SH
    BIOCHEMICAL JOURNAL, 1995, 309 : 445 - 452
  • [2] Endomorphins inhibit high-threshold Ca2+ channel currents in rodent NG108-15 cells overexpressing μ-opioid receptors
    Higashida, H
    Hoshi, N
    Knijnik, R
    Zadina, JE
    Kastin, AJ
    JOURNAL OF PHYSIOLOGY-LONDON, 1998, 507 (01): : 71 - 75
  • [3] In vitro changes in capacitative Ca2+ entry in neuroblastoma X glioma NG108-15 cells
    Ichikawa, J
    Fukuda, Y
    Yamashita, M
    NEUROSCIENCE LETTERS, 1998, 246 (02) : 120 - 122
  • [4] Evidence for several mechanisms of volume regulation in neuroblastoma x glioma hybrid NG108-15 cells
    Rouzaire-Dubois, B
    Bostel, S
    Dubois, JM
    NEUROSCIENCE, 1999, 88 (01) : 307 - 317
  • [5] DISSECTION OF BRADYKININ-EVOKED RESPONSES BY BUFFERING INTRACELLULAR CA2+ IN NEUROBLASTOMA X GLIOMA HYBRID NG108-15 CELLS
    KIMURA, Y
    HIGASHIDA, H
    NEUROSCIENCE RESEARCH, 1992, 15 (03) : 213 - 220
  • [6] INTRACELLULAR CALCIUM POOLS IN NEUROBLASTOMA X GLIOMA HYBRID NG108-15 CELLS
    CHUEH, SH
    LIU, JA
    KAO, LS
    JOURNAL OF NEUROCHEMISTRY, 1990, 55 (04) : 1281 - 1286
  • [7] Involvement of voltage-activated Ca2+ channels in ATP- and UTP-induced calcium signalling in neuroblastoma glioma hybrid cells (NG108-15)
    Bräter, M
    Gorodjezkaya, IJ
    Andreas, K
    EUROPEAN JOURNAL OF NEUROSCIENCE, 1998, 10 : 178 - 178
  • [8] BLOCK OF CALCIUM CHANNELS BY ENKEPHALIN AND SOMATOSTATIN IN NEUROBLASTOMA GLIOMA HYBRID NG108-15 CELLS
    TSUNOO, A
    YOSHII, M
    NARAHASHI, T
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (24) : 9832 - 9836
  • [9] Studies on the prevention of nigericin action in neuroblastoma x glioma hybrid (NG108-15) cells
    Doebler, JA
    PHARMACOLOGY & TOXICOLOGY, 2000, 87 (02): : 63 - 68
  • [10] PHOSPHOINOSITIDES AND SYNAPTIC FUNCTION IN NG108-15 NEUROBLASTOMA X GLIOMA HYBRID-CELLS
    HIGASHIDA, H
    YOKOYAMA, S
    HOSHI, N
    MYOJO, Y
    KAWAMURA, T
    ITO, Y
    HASHII, M
    SAGARA, J
    FURUYA, K
    COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-PHARMACOLOGY TOXICOLOGY & ENDOCRINOLOGY, 1991, 98 (01): : 129 - 137